205 related articles for article (PubMed ID: 33299887)
1. Proteomic Profiling Change and Its Implies in the Early Mycosis Fungoides (MF) Using Isobaric Tags for Relative and Absolute Quantification (iTRAQ).
Zhu M; Li Y; Ding C; Wang J; Ma Y; Li Z; Zhang X; Wang P
Biomed Res Int; 2020; 2020():9237381. PubMed ID: 33299887
[TBL] [Abstract][Full Text] [Related]
2. Tape stripped stratum corneum samples are suitable for diagnosis and comprehensive proteomic investigation in mycosis fungoides.
Qureshi HA; Azimi A; Wells J; Fernandez-Penas P
Proteomics Clin Appl; 2023 May; 17(3):e2200039. PubMed ID: 36824058
[TBL] [Abstract][Full Text] [Related]
3. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation.
Hu SC; Lin CL; Hong CH; Yu HS; Chen GS; Lee CH
J Dermatol Sci; 2014 Apr; 74(1):31-8. PubMed ID: 24411580
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomic analysis by iTRAQ for identification of candidate biomarkers in plasma from acute respiratory distress syndrome patients.
Chen X; Shan Q; Jiang L; Zhu B; Xi X
Biochem Biophys Res Commun; 2013 Nov; 441(1):1-6. PubMed ID: 24041686
[TBL] [Abstract][Full Text] [Related]
5. Tissue and serum lipidome shows altered lipid composition with diagnostic potential in mycosis fungoides.
Xu C; Zhou D; Luo Y; Guo S; Wang T; Liu J; Liu Y; Li Z
Oncotarget; 2017 Jul; 8(29):48041-48050. PubMed ID: 28624795
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
7. [Clinical heterogeneity of poikilodermatous mycosis fungoides: A retrospective study of 12 cases].
Rohmer E; Mitcov M; Cribier B; Lipsker D; Lenormand C
Ann Dermatol Venereol; 2020; 147(6-7):418-428. PubMed ID: 32229035
[TBL] [Abstract][Full Text] [Related]
8. Mycosis fungoides in plaque stage with pronounced eosinophilic infiltration, folliculotropism, and concomitant invasive squamous cell carcinoma.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):749-56. PubMed ID: 23573323
[TBL] [Abstract][Full Text] [Related]
9. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD31 in Mycosis Fungoides.
Jankowska-Konsur A; Kobierzycki C; Grzegrzolka J; Piotrowska A; Gomulkiewicz A; Glatzel-Plucinska N; Olbromski M; Podhorska-Okolow M; Szepietowski JC; Dziegiel P
Anticancer Res; 2016 Sep; 36(9):4575-82. PubMed ID: 27630298
[TBL] [Abstract][Full Text] [Related]
11. Potential role for microRNA-16 (miR-16) and microRNA-93 (miR-93) in diagnosis and prediction of disease progression in mycosis fungoides in Egyptian patients.
Talaat IM; Abdelmaksoud RE; Guimei M; Agamia NF; Nugud A; El-Serafi AT
PLoS One; 2019; 14(10):e0224305. PubMed ID: 31648231
[TBL] [Abstract][Full Text] [Related]
12. The different faces of mycosis fungoides: results of a single-center study.
Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
[TBL] [Abstract][Full Text] [Related]
13. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S
Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of mycosis fungoides: a comparative immunohistochemical study of T-cell markers using a novel anti-CD7 antibody.
Cotta AC; Cintra ML; de Souza EM; Chagas CA; Magna LA; Fleury RN; Brousset P; Vassallo J
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):291-5. PubMed ID: 16932019
[TBL] [Abstract][Full Text] [Related]
15. Gene Expression Profiling of Mycosis Fungoides in Early and Tumor Stage-A Proof-of-Concept Study Using Laser Capture/Single Cell Microdissection and NanoString Analysis.
Lai J; Li J; Gniadecki R; Lai R
Cells; 2021 Nov; 10(11):. PubMed ID: 34831413
[TBL] [Abstract][Full Text] [Related]
16. miR-155 is involved in tumor progression of mycosis fungoides.
Moyal L; Barzilai A; Gorovitz B; Hirshberg A; Amariglio N; Jacob-Hirsch J; Maron L; Feinmesser M; Hodak E
Exp Dermatol; 2013 Jun; 22(6):431-3. PubMed ID: 23711069
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of human frontal and temporal cortex using iTRAQ-based 2D LC-MS/MS.
Xu L; Sun H; Zhang Y; Guo Z; Xiao X; Zhou X; Hu K; Sun W; Wang B; Liu W
Chin Neurosurg J; 2021 May; 7(1):27. PubMed ID: 33952343
[TBL] [Abstract][Full Text] [Related]
18. Utility of CD30, Ki-67, and p53 in assisting with the diagnosis of mycosis fungoides with large cell transformation.
Raghavan SS; Hong EK; Kim YH; Kim J
J Cutan Pathol; 2019 Jan; 46(1):33-43. PubMed ID: 30328119
[TBL] [Abstract][Full Text] [Related]
19. CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases.
Yuki A; Shinkuma S; Hayashi R; Fujikawa H; Kato T; Homma E; Hamade Y; Onodera O; Matsuoka M; Shimizu H; Iwata H; Abe R
J Am Acad Dermatol; 2018 Dec; 79(6):1039-1046. PubMed ID: 29928911
[TBL] [Abstract][Full Text] [Related]
20. Proteome and cytokine serum profiling to diagnose a mycosis fungoides.
Moshkovskii SA; Sokolova EE; Brattseva EV; Karpova MA; Pyatnitskiy MA; Kubanova AA; Archakov AI
Proteomics Clin Appl; 2011 Aug; 5(7-8):432-9. PubMed ID: 21751413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
